Cyanotech Corporation (CYAN)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 09:47AM EDT. Market open.
| Previous close | 0.2906 |
| Open | 0.3050 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 1200 |
| Day's range | 0.3050 - 0.3050 |
| 52-week range | 0.1200 - 1.1600 |
| Volume | |
| Avg. volume | 23,873 |
| Market cap | 2.1M |
| Beta (5Y monthly) | 0.28 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Nutrex-Hawaii Introduces Its #1 Selling BioAstin® Hawaiian Astaxanthin® in a Retail-Ready, Sugar-Free, Vegan Gummy Format
KAILUA KONA, Hawaii, March 28, 2024--Nutrex-Hawaii, Inc., a wholly owned subsidiary of Cyanotech Corporation, unveils its #1 selling BioAstin® Hawaiian Astaxanthin® dietary supplement in a groundbreaking sugar free gummy format, enriched with an industry-leading 12mg of natural Hawaiian Astaxanthin per daily serving.
- Business Wire
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2024
KAILUA KONA, Hawaii, February 08, 2024--Cyanotech Reports Financial Results for Q3FY24
- Business Wire
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024
KAILUA KONA, Hawaii, November 08, 2023--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024
© 2024 Yahoo. All rights reserved.